Berkeley, CA, United States of America

Keith Nykamp

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Laboratory Corporation of America Holdings. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keith Nykamp: Innovator in Population Frequency Modeling

Introduction

Keith Nykamp is a notable inventor based in Berkeley, CA (US). He has made significant contributions to the field of genetics through his innovative patent. His work focuses on improving the understanding of variant pathogenicity estimation, which is crucial for advancing personalized medicine.

Latest Patents

Keith Nykamp holds a patent titled "Population frequency modeling for quantitative variant pathogenicity estimation." This patent describes a method that applies a logistic regression model to a set of population data for various genes. The technology utilizes features that quantify the predictive value of allele frequency within a gene. By evaluating the output of the logistic regression model against expected variant classifications, the model is refined to produce accurate variant pathogenicity estimates.

Career Highlights

Keith Nykamp is associated with Laboratory Corporation of America Holdings, a leading company in the field of laboratory testing and diagnostics. His work at the company has allowed him to contribute to advancements in genetic research and variant analysis.

Collaborations

Throughout his career, Keith has collaborated with talented individuals such as Toby Manders and Yuya Kobayashi. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.

Conclusion

Keith Nykamp's contributions to population frequency modeling and variant pathogenicity estimation highlight his role as an influential inventor in the field of genetics. His work continues to pave the way for advancements in personalized medicine and genetic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…